Cite
HARVARD Citation
Alten, R. et al. (n.d.). SAT0161 Preliminary real world data on switching patterns between etanercept, its recently marketed biosimilar counterpart and its competitor adalimumab, using swedish prescription registry. Annals of the rheumatic diseases. p. 831. [Online].